279 related articles for article (PubMed ID: 20615167)
1. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population.
Stephenson JJ; Quimbo RA; Gutierrez B
Am J Manag Care; 2010 Feb; 16(2):108-14. PubMed ID: 20148615
[TBL] [Abstract][Full Text] [Related]
4. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
[TBL] [Abstract][Full Text] [Related]
5. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
6. Short-acting β-agonist use and its ability to predict future asthma-related outcomes.
Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877
[TBL] [Abstract][Full Text] [Related]
7. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
O'Connor RD; Bleecker ER; Long A; Tashkin D; Peters S; Klingman D; Gutierrez B
J Asthma; 2010 May; 47(4):422-8. PubMed ID: 20528597
[TBL] [Abstract][Full Text] [Related]
8. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
Navaratnam P; Friedman HS; Urdaneta E
Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
10. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
12. Continuity of prescribers of short-acting beta agonists among children with asthma.
Dombkowski KJ; Harrison SR; Cohn LM; Lewis TC; Clark SJ
J Pediatr; 2009 Dec; 155(6):788-94. PubMed ID: 19683253
[TBL] [Abstract][Full Text] [Related]
13. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
Smith MJ; Rascati KL; McWilliams BC
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):40-6. PubMed ID: 14756463
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
15. Ratio of controller to total asthma medications: determinants of the measure.
Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
[TBL] [Abstract][Full Text] [Related]
16. [Predictive factors associated with severity of asthma exacerbations].
Atiş S; Kaplan ES; Ozge C; Bayindir S
Tuberk Toraks; 2008; 56(2):187-96. PubMed ID: 18701979
[TBL] [Abstract][Full Text] [Related]
17. Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women.
Firoozi F; Ducharme FM; Lemière C; Beauchesne MF; Perreault S; Forget A; Blais L
Respir Med; 2009 Jan; 103(1):144-51. PubMed ID: 18760909
[TBL] [Abstract][Full Text] [Related]
18. Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations.
Paris J; Peterson EL; Wells K; Pladevall M; Burchard EG; Choudhry S; Lanfear DE; Williams LK
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):482-7. PubMed ID: 19055201
[TBL] [Abstract][Full Text] [Related]
19. Does pre-hospital telephone communication with a clinician result in more appropriate medication administration by parents during childhood asthma exacerbations?
Garro AC; Fearon D; Koinis-Mitchell D; McQuaid EL
J Asthma; 2009 Nov; 46(9):916-20. PubMed ID: 19905918
[TBL] [Abstract][Full Text] [Related]
20. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
Thomas M; von Ziegenweidt J; Lee AJ; Price D
J Allergy Clin Immunol; 2009 Jan; 123(1):116-121.e10. PubMed ID: 18986690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
